We are live on
!
Find out more
AVM
Avalon Ventures Management Portfolio holdings
AUM
$14.2M
1-Year Est. Return
9.35%
This Fund
S&P 500
This Quarter
Est. Return
+5.79%
1 Year Est. Return
+9.35%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19M
AUM Growth
+$2.17M
(+13%)
Cap. Flow
+$1.14M
Cap. Flow
% of AUM
6%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Janux Therapeutics
JANX
|
+$1.14M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 94.74% |
| 2 | Healthcare | 5.26% |
Similar funds
RCMU
LM
KL
SI
TAC
TPC
DADR
PM
Avalon Ventures Management's Q2 2025 Portfolio in Review
As of Q2 2025, Avalon Ventures Management held 2 positions worth $19M, up 13% from $16.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Avalon Ventures Management deployed $1.14M of net new capital in Q2 2025, opening 1 new position. Its largest new stake was Janux Therapeutics: 43,300 shares worth $1M.
By sector, the portfolio is most concentrated in Technology at 95% of assets, down from 100% a quarter earlier, followed by Healthcare.
- Avalon Ventures Management's largest Q2 2025 buy was Janux Therapeutics: 43,300 shares worth $1M.
- Avalon Ventures Management's ten largest holdings make up 100% of its $19M portfolio in Q2 2025.
- Avalon Ventures Management opened 1 new position and closed 0 in Q2 2025.
- Avalon Ventures Management's portfolio value rose 13% quarter-over-quarter to $19M.
Based on Avalon Ventures Management's 13F filing for Q2 2025, filed 25 Jul 2025.